ebselen has been researched along with Diabetes Mellitus, Type 1 in 1 studies
ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tan, SM | 1 |
| Sharma, A | 1 |
| Stefanovic, N | 1 |
| de Haan, JB | 1 |
1 other study available for ebselen and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Late-intervention study with ebselen in an experimental model of type 1 diabetic nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Azoles; Deoxyguanosine; Diabetes Mellitus, Type | 2015 |